// App-Quantinova.ai

2054 : Genetic landscape of extreme responders with anaplastic oligodendroglioma: NRG Oncology/RTOG 9402.

Researchers

Presenter

  • Matthias Holdhoff

Principal Investigators

  • Robert B. Jenkins

  • Chetan Bettegowda

  • Ming Zhang

  • Thomas M. Kollmeyer

  • Srinivasan T. Yegnasubramanian

  • Stuart A. Grossman

  • Bert Vogelstein

  • Nickolas Papadopoulos

  • Kenneth W. Kinzler

  • Maria Werner-Wasik

  • Luis Souhami

  • Jean-Paul Bahary

  • Young Kwok

  • Alan C. Hartford

  • Peixin Zhang

  • Arnab Chakravarti

  • Minesh P. Mehta

Medical Centers

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Charbonneau Cancer Institute at the University of Calgary, Calgary, AB, Canada

  • Mayo Clinic, Rochester, MN

  • Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins, Baltimore, MD

  • Thomas Jefferson University, Philadelphia, PA

  • McGill University Health Centre, Montreal, QC, Canada

  • Centre Hospitalier de l'Universite de Montreal, Montreal University, Montreal, QC, Canada

  • University of Maryland Medical Center, Baltimore, MD

  • Dartmouth Hitchcock Medical Center, Lebanon, NH

  • NRG Oncology Statistics and Data Management Center, Philadelphia, PA

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anaplastic oligodendroglial tumors

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved